Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol-Myers Squibb Foundation Donates Funds For Hepatitis Awareness, Prevention In China

This article was originally published in PharmAsia News

Executive Summary

BEIJING - Aimed at combating a leading cause of death in the world's most populous nation, the Bristol-Myers Squibb Foundation is setting up partnerships with public health groups across China to promote awareness and prevention of hepatitis

You may also be interested in...



Will World's Largest HCV Population Have Access To Newest Treatments?

With a large patient pool and a recent expansion of government reimbursement for costly peg-interferon therapies, China is poised to see an exponential growth in its hepatitis C virus treatment market, growing north of 80% in five years, according to a recent report by research firm Decision Resources

Will World's Largest HCV Population Have Access To Newest Treatments?

With a large patient pool and a recent expansion of government reimbursement for costly peg-interferon therapies, China is poised to see an exponential growth in its hepatitis C virus treatment market, growing north of 80% in five years, according to a recent report by research firm Decision Resources

Will World's Largest HCV Population Have Access To Newest Treatments?

Merck will work with the Chinese Physician Association on an HCV awareness campaign.

Related Content

UsernamePublicRestriction

Register

SC070816

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel